Cargando…
RPS9 promotes the progression of NSCLC via activation Stat3 and Erk signaling pathways
Background: Non-small cell lung cancer (NSCLC) accounts for the largest pathological type of lung cancers, and it is characterized by high incidence and poor prognosis. However, the molecular mechanisms involved in development and progression of NSCLC are not well elucidated. In this study, we aimed...
Autores principales: | Kong, Yiru, Shuangshuang, Deng, Liang, Xiaohua, Zhou, Xinli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899376/ https://www.ncbi.nlm.nih.gov/pubmed/35281852 http://dx.doi.org/10.7150/jca.67513 |
Ejemplares similares
-
MIB2 promotes the progression of non-small cell lung cancer by regulating cell cycle control pathways
por: Kong, Yiru, et al.
Publicado: (2023) -
RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
por: Shi, Rui, et al.
Publicado: (2022) -
PSMC2 promotes the progression of gastric cancer via induction of RPS15A/mTOR pathway
por: Liu, Tao, et al.
Publicado: (2022) -
RASSF9 promotes NSCLC cell proliferation by activating the MEK/ERK axis
por: Yuan, Jun, et al.
Publicado: (2021) -
RPS15A promotes gastric cancer progression via activation of the Akt/IKK‐β/NF‐κB signalling pathway
por: Liu, Chenchen, et al.
Publicado: (2019)